Lp(a) is actionable now. Get tested! Know your number.
#lipids #LPa
Some cardiologists are reaching a turning point.
Lp(a) is actionable now. Get tested! Know your number.
#lipids #LPa
@glaucomflecken.bsky.social who says cardiology and nephrology can’t work together?
🔗 https://ow.ly/YXWE50XQ4IJ
#CKD #HeartHealth #PreventiveCardiology #CVDPrevention #PublicHealth #CardioSky #MedSky
@glaucomflecken.bsky.social who says cardiology and nephrology can’t work together?
90-Second Cardio-OB Journal Scan
with @cardioobdoc.bsky.social
Association between HDP & Premature CVD
🗞️ Nov 28, 2025 @ahajournals.bsky.social
🔗 www.ahajournals.org/doi/10.1161/...
#ACCRepOB #ACCCardioOB #CardioObstetrics #CardioSky @erinmichos.bsky.social @shantelleb.bsky.social
90-Second Cardio-OB Journal Scan
with @cardioobdoc.bsky.social
Association between HDP & Premature CVD
🗞️ Nov 28, 2025 @ahajournals.bsky.social
🔗 www.ahajournals.org/doi/10.1161/...
#ACCRepOB #ACCCardioOB #CardioObstetrics #CardioSky @erinmichos.bsky.social @shantelleb.bsky.social
Read: www.sciencedirect.com/science/arti...
#PreventiveCardiology #HeartHealth #ASPC #cardiosky #medsky
Read: www.sciencedirect.com/science/arti...
#PreventiveCardiology #HeartHealth #ASPC #cardiosky #medsky
Sponsored by @vindicomeded.bsky.social & @gohealio.bsky.social
www.healio.com/cme/mededtal...
Sponsored by @vindicomeded.bsky.social & @gohealio.bsky.social
www.healio.com/cme/mededtal...
Featuring @erinmichos.bsky.social (women’s health leader @HopkinsHeart) @anabarac (pioneer in cardio-oncology), masterfully chaired by @sharonmulvagh expert in Echo and women’s CV health
Featuring @erinmichos.bsky.social (women’s health leader @HopkinsHeart) @anabarac (pioneer in cardio-oncology), masterfully chaired by @sharonmulvagh expert in Echo and women’s CV health
@erinmichos.bsky.social @johnshopkinssph.bsky.social @jhu.edu @imperialcollegeldn.bsky.social @uthsc.bsky.social
@erinmichos.bsky.social @johnshopkinssph.bsky.social @jhu.edu @imperialcollegeldn.bsky.social @uthsc.bsky.social
@erinmichos.bsky.social @ciccaronecenter.bsky.social
Quick read our case 🔗 @accintouch.bsky.social
learn.acc.org/Page/Bempedo...
@erinmichos.bsky.social @ciccaronecenter.bsky.social
Quick read our case 🔗 @accintouch.bsky.social
learn.acc.org/Page/Bempedo...
📱💡 Personalized care matters.
ow.ly/H8ob50WrnQk
#Hypertension #Cardiology #mHealth #AJPC
📱💡 Personalized care matters.
ow.ly/H8ob50WrnQk
#Hypertension #Cardiology #mHealth #AJPC
Official journal @aspcardio.bsky.social, AJPC is on the rise — thanks to Dr. Nathan Wong, @erinmichos.bsky.social, & our incredible community.
www.sciencedirect.com/journal/amer...
www.aamc.org/about-us/aam...
@cardioobdoc.bsky.social @arghavansallesmd.medsky.social @erinmichos.bsky.social @drmarthagulati.bsky.social
www.aamc.org/about-us/aam...
@cardioobdoc.bsky.social @arghavansallesmd.medsky.social @erinmichos.bsky.social @drmarthagulati.bsky.social
www.lipidjournal.com/article/S193...
www.lipidjournal.com/article/S193...
www.sciencedirect.com/science/arti...
#CardioSky @aspcardio.bsky.social
www.sciencedirect.com/science/arti...
#CardioSky @aspcardio.bsky.social
Watch the interview here: www.hcplive.com/view/post-me...
Watch the interview here: www.hcplive.com/view/post-me...
for wining JACC authorship awards for work in Maternal CV Health 👏🏼👏🏼👏🏼
@erinmichos.bsky.social
@hopkinsheart.bsky.social
@accintouch.bsky.social @janetcatov #acc2025
Fri, May 30 | 7:15–8:45 AM at JW Marriott Miami Turnberry Resort and Spa #NLASessions
🔗 vindicoce.com/NLA
@nationallipid.bsky.social @erinmichos.bsky.social @foundationofnla.bsky.social @lipidjournal.bsky.social
Fri, May 30 | 7:15–8:45 AM at JW Marriott Miami Turnberry Resort and Spa #NLASessions
🔗 vindicoce.com/NLA
@nationallipid.bsky.social @erinmichos.bsky.social @foundationofnla.bsky.social @lipidjournal.bsky.social
@erinmichos.bsky.social
@nationallipid.bsky.social
@lipidjournal.bsky.social
@foundationofnla.bsky.social
@erinmichos.bsky.social
@nationallipid.bsky.social
@lipidjournal.bsky.social
@foundationofnla.bsky.social
A new trial suggests promise for broadening the therapeutic landscape for patients with pre-existing or high risk for ASCVD.
Find out more in our latest issue: tinyurl.com/4vjusubm